These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18666851)

  • 1. Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers.
    Toh SA; Rader DJ
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1007-22. PubMed ID: 18666851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How can we prevent cardiovascular disease in diabetes.
    Wiklund O; Håversen L; Pettersson C; Hultén LM
    J Intern Med; 2007 Aug; 262(2):199-207. PubMed ID: 17645587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing cardiometabolic risk: an evolving approach to patient care.
    Watson K
    Crit Pathw Cardiol; 2007 Mar; 6(1):5-14. PubMed ID: 17667880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 8. Adipokines--targeting a root cause of cardiometabolic risk.
    Bakhai A
    QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)].
    Farnier M
    Arch Mal Coeur Vaiss; 2007 Dec; 100(12):979-84. PubMed ID: 18223510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating the metabolic syndrome.
    Bianchi C; Penno G; Romero F; Del Prato S; Miccoli R
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):491-506. PubMed ID: 17489673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity: a main factor of metabolic syndrome?
    Licata G; Argano C; Di Chiara T; Parrinello G; Scaglione R
    Panminerva Med; 2006 Jun; 48(2):77-85. PubMed ID: 16953145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update.
    Selwyn AP
    Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
    Qatanani M; Lazar MA
    Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.